Counseling on Fertility and Reproductive Health in Desmoid Tumor Management

This section centers specifically on reproductive health considerations in patients with desmoid tumor. Given that desmoid tumor frequently affects younger adults, fertility counseling is an essential component of comprehensive care. The panel discusses how certain systemic therapies, particularly gamma secretase inhibitors, have been associated with ovarian dysfunction, raising important questions about reversibility and long-term reproductive implications.

The discussion emphasizes that conversations about fertility should occur before initiating systemic therapy. Patients of childbearing potential should be informed about possible risks, the available evidence regarding ovarian suppression, and the potential for recovery after discontinuation when data are available. Transparent counseling allows patients to weigh treatment urgency against family planning goals.

Referral to reproductive endocrinology specialists may be appropriate for patients interested in fertility preservation strategies. The panel highlights the importance of shared decision making, particularly when balancing symptom control with long-term reproductive considerations. In some cases, treatment timing may be influenced by personal plans regarding pregnancy.

Ultimately, integrating fertility counseling into desmoid tumor management reflects a patient-centered approach that extends beyond tumor control. Addressing reproductive health proactively ensures that therapeutic decisions align with both medical priorities and individual life goals.